Expertise in
18
conditions

Paola Giunti

UCL Queen Square Institute Of Neurology, 
London, ENG, GB 
Expertise in
18
conditions
UCL Queen Square Institute Of Neurology, 
London, ENG, GB 

Overview

Paola Giunti practices practicing medicine in London, United Kingdom.

Ms. Giunti is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Friedreich Ataxia, Spinocerebellar Ataxia, Drug Induced Dyskinesia, and Hereditary Ataxia.

She is actively involved in clinical research, co-authoring 158 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

UCL Queen Square Institute Of Neurology, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedreich's Ataxia (MOXIe)
A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedreich's Ataxia (MOXIe)
Enrollment Status: Completed
Publish Date: September 03, 2026
Intervention Type: Drug
Study Drug: Omaveloxolone
Study Phase: Phase 2
Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Enrollment Status: Completed
Publish Date: October 03, 2025
A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3
A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3
Enrollment Status: Terminated
Publish Date: August 04, 2023
Intervention Type: Drug
Study Drug: BIIB132
Study Phase: Phase 1
View 2 Less Clinical Trials

158 Total Publications

Ataxia patient care pathway and associated healthcare costs in Italy: a cross-sectional survey.
Ataxia patient care pathway and associated healthcare costs in Italy: a cross-sectional survey.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: March 04, 2026

Frequently Asked Questions about Paola Giunti

Is Paola Giunti a top-rated expert for Friedreich Ataxia?

MediFind is an objective health platform that identifies experts based on real-world data. Paola Giunti is classified as an Elite expert for Friedreich Ataxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Paola Giunti participate in research or clinical trials?

Yes. Paola Giunti has published 158 articles and abstracts on conditions like Friedreich Ataxia. You can view a list of Paola Giunti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Giunti's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 32 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile